V-LoveTM now
available in London Drugs stores
VANCOUVER, BC -- June
29,2015 -- InvestorsHub NewsWire -- Enertopia Corporation
(ENRT-OTCBB) (TOP-CSE) (the "Company" or "Enertopia") is
pleased to announce V-LoveTM is now available for
purchase in 30 London Drugs stores and is to be in all 79 stores by
Friday July 3rd.
The first shipment of
V-LoveTM to the London Drugs main distribution facility
in Richmond, BC was received and is in the process of being
redistributed to all London Drugs stores across Western
Canada.
V-LoveTM can
also be purchased online at Londondrugs.com for your personal
convenience and can be shipped anywhere in
Canada.
V-LoveTM is pH
balanced specifically for women and provides lubrication and a
moisturizing feeling to sooth vaginal dryness.
V-LoveTM It
all begins with desire
We are very pleased to be
in a growing number of stores and look forward to growing our
V-Love TM brand name, stated President Robert
McAllister.
About
Enertopia
The Companys mission is
to empower people with a better way of living through healthy
lifestyle choices in helping you live your life your way. Our core
values of honesty, integrity, and commitment help to define our
corporate practices and demonstrate our dedication in helping
individuals whether they are encountering health issues based on
age, diet or have suffered a traumatic physical, mental or an
emotional event.
Enertopias shares are
quoted in Canada with symbol TOP and in the United States with
symbol ENRT. For additional information, please visit
www.enertopia.com or call Robert McAllister, the President: (250)
765-6412
This release includes
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Statements which are
not historical facts are forward-looking statements. The Company
makes forward-looking public statements concerning its expected
future financial position, results of operations, cash flows,
financing plans, business strategy, products and services,
potential and financing of its medical marihuana projects,
evaluation and sale of sexual creams and other items, competitive
positions, growth opportunities, plans and objectives of management
for future operations, including statements that include words such
as "anticipate," "if," "believe," "plan," "estimate," "expect,"
"intend," "may," "could," "should," "will," and other similar
expressions that are forward-looking statements. Such
forward-looking statements are estimates reflecting the Company's
best judgment based upon current information and involve a number
of risks and uncertainties, and there can be no assurance that
other factors will not affect the accuracy of such forward-looking
statements., foreign exchange and other financial markets; changes
of the interest rates on borrowings; hedging activities; changes in
commodity prices; changes in the investments and exploration
expenditure levels; litigation; legislation; environmental,
judicial, regulatory, political and competitive developments in
areas in which Enertopia Corporation operates. The
User should refer to the risk disclosures set out in the periodic
reports and other disclosure documents filed by Enertopia
Corporation from time to time with regulatory authorities. There is
no assurance that V-Love TM will have any meaningful
impact on the Company or the Company will be able to obtain future
financings.
The CSE has not reviewed
and does not accept responsibility for the adequacy or accuracy of
this release
